Fig. 6
AXL as a potential drug target for the glycolytic phenotype. a Immunofluorescence staining shows detectable AXL receptor expression levels only on the 2-NBDGhigh cells in the MPE sample of P29 (scale bar, 10 μm). b Cell viability of 2-NBDGhigh cells upon AXL inhibition across three patient MPE samples with different genotypes (n = 3 independent experiments, mean ± SD, two-tailed Student’s t-test, *P < 0.05). c Cell viability of C12Rhigh cells upon AXL inhibition across three patient MPE samples with different genotypes (n = 3 independent experiments, mean ± SD). No statistically significant difference in cell viability is observed between drug and DMSO treated cells. Source data are provided as a Source Data file
